Extended Abstract

The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients

Authors: Jean Hansen (Univeristy of Iowa, Iowa City, IA) , Jean-Marie Stephan (University of Iowa, Iowa City, IA) , Michelle Freesmeier (University of Iowa, Iowa City, IA) , David P Bender (University of Iowa, Iowa City, IA) , Koen De Geest , Anna Button (University of Iowa, Iowa City, IA) , Michael J. Goodheart (University of Iowa, Iowa City, IA)

  • The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients

    Extended Abstract

    The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients

    Authors: , , , , , ,

Options

Abstract

The American Society of Clinical Oncology recommends that full weight-based doses of chemotherapy be used to treat obese patients with cancer. However, many oncologists limit the dose of chemotherapy based on ideal body weight or a maximum body surface area (BSA) of m2. The objective of our study is to determine how weight-based chemotherapy dosing affects toxicity, treatment delays, and laboratory values in a cohort of obese gynecologic cancer patients at our institution. We hypothesize that full weight-based dosing in obese patients does not increase adverse chemotherapy outcomes.

Keywords: chemotherapy, obesity, dosage

How to Cite:

Hansen, J. & Stephan, J. & Freesmeier, M. & Bender, D. P. & De Geest, K. & Button, A. & Goodheart, M. J., (2013) “The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients”, Proceedings in Obstetrics and Gynecology 3(3), 1–2. doi: https://doi.org/10.17077/2154-4751.1235

Rights: Copyright © Jean Hansen, Jean-Marie Stephan, Michelle Freesmeier, David P. Bender, Koen De Geest, Anna Button, Michael J. Goodheart, 2013

Downloads:
Download pdf
View PDF

412 Views

299 Downloads

Published on
01 Dec 2013
Peer Reviewed
License
CC BY 3.0